UCB-9260
UCB-9260, an orally active compound, inhibits TNF signaling by stabilising an asymmetric form of the trimer. UCB-9260 is selective for TNF over other superfamily members, and binds TNF with a similar Kd of 13 nM[1].
Product Specifications
CAS Number
[1515888-53-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/ucb-9260.html
Purity
98.38
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OC(C1=CC=NC=C1)C2=NC3=CC=C(C4=CN(C)N=C4)C=C3N2CC5=CC(C)=CC=C5C
Molecular Formula
C26H25N5O
Molecular Weight
423.51
Precautions
H302, H315, H319
References & Citations
[1]O'Connell J, et al.Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer.Nat Commun. 2019 Dec 19;10 (1) :5795.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7076318 Inquire
Recombinant Rat Tumor suppressor candidate 5 homolog (Tusc5), partial
Ask
View Details 036762-ML405 100 µL
HRH1, ID (HRH1, Histamine H1 receptor) (MaxLight 405) discontinued
Ask
View Details 